Recent advances in applying nanotechnologies for cancer immunotherapy.

J Control Release 2018 10 14;288:239-263. Epub 2018 Sep 14.

Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver Campus, 5519-2405 Wesbrook Mall, Vancouver, British Columbia V6T 1Z3, Canada;. Electronic address:

Cancer immunotherapy aimed at boosting cancer-specific immunoresponses to eradicate tumor cells has evolved as a new treatment modality. Nanoparticles incorporating antigens and immunomodulatory agents can activate immune cells and modulate the tumor microenvironment to enhance anti-tumor immunity. The nanotechnology approach has been demonstrated to be superior to standard formulations in in-vivo settings. In this article, we focus on recent advances made within the last 5 years in nanoparticle-based cancer immunotherapy, including peptide- and nucleic acid-based nanovaccines, nanomedicines containing an immunoadjuvant to activate anti-tumor immunity, nanoparticle delivery of immune checkpoint inhibitors and the combination of the above approaches. Encouraging results and new emerging nanotechnologies in drug delivery promise the continuous growth of this field and ultimately clinical translation of enhanced immunotherapy of cancer.

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01683659183052
Publisher Site
http://dx.doi.org/10.1016/j.jconrel.2018.09.010DOI Listing
October 2018

Publication Analysis

Top Keywords

cancer immunotherapy
12
immunotherapy cancer
8
anti-tumor immunity
8
encouraging emerging
4
superior standard
4
emerging nanotechnologies
4
demonstrated superior
4
settings article
4
approaches encouraging
4
formulations in-vivo
4
standard formulations
4
approach demonstrated
4
in-vivo settings
4
nanotechnology approach
4
tumor microenvironment
4
modulate tumor
4
cells modulate
4
microenvironment enhance
4
enhance anti-tumor
4
article focus
4

Similar Publications